Tech Company Financing Transactions
Relation Therapeutics Funding Round
Relation Therapeutics secured a $35 million Seed funding round on 3/15/2024. Investors included DCVC, Nventures and ARK Investment Management.
Transaction Overview
Company Name
Announced On
3/15/2024
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance its osteoporosis pipeline towards the clinic, as well as initiate discovery campaigns in new therapeutic areas of high unmet need.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Regent's Place 338 Euston Road
London, NW1 3BT
UK
London, NW1 3BT
UK
Phone
Undisclosed
Website
Email Address
Overview
Embedding the patient, from the earliest stages of innovation. We constantly ask which new technologies will allow us to drive the progression of our programmes. To do this, we create experimental and computational systems to understand the biological processes in human health and disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Charles Roberts
Chief Executive Officer
David Roblin
Chief Operating Officer
Benjamin Swerner
Chief Scientific Officer
Edith Hessel
Chief Technical Officer
Lindsay Edwards
VP - Operations
Rosie Rodriguez
Browse more venture capital transactions:
Prev: 3/15/2024: Vawlt venture capital transaction
Next: 3/16/2024: Murphy's Naturals venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs